Jul 2026 (Q4 FY26) — Aug 26, 2026
Donaldson Company Q4 FY26 — Record Sales and Operating Margin, Strong FY27 Outlook
Read the full callDonaldson Company earnings: last reported Wed, 26 Aug 2026, for the quarter ended Jul 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 1,059 | Quarterly, as filed | Quarter to Jul 2026 | Revenue from operations as filed. No quarter a year earlier is in the series, so no change is shown. | |
| Operating margin | 16.7 | Operating profit / revenue | Quarter to Jul 2026 | For the quarter; a change is in percentage points. No quarter a year earlier is in the series, so no change is shown. | |
| Net profit | 129 | Quarterly, as filed | Quarter to Jul 2026 | Profit after tax as filed. No quarter a year earlier is in the series, so no change is shown. |
Guidance
13 of 31 judged targets kept · 43 open · verdicts reflect calls analysed to Jul 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Adjusted EPS | $3.92 to $4.08 | Jul 2025 | grew EPS 8% to a record $3.98 | Achieved |
| Aerospace and Defense Sales Growth | flat | Jul 2025 | Organic aerospace and defense sales declined 3% as overall supply chain constraints, while incrementally improving in some areas persist. | Missed |
| Adjusted EPS | between $4.22 and $4.38 | Jul 2026 | All in, our EPS guidance for the full year is between $4.22 and $4.38, including approximately $0.12 of dilution from Facet when considering incremental amortization and additional interest expense. | New |
18 of DONALDSON Co INC's 74 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 71 more targets are in the full ledger.
Claimed
Qualified
Price
1Y: $254.9 on 21 Oct 2025 → $84.79. High $400.45 (7 Apr 2026), low $84.79 (23 Oct 2026).
Overview
Guidance
13 of 31 judged targets kept · 43 open · verdicts reflect calls analysed to Jul 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Adjusted EPS | $3.92 to $4.08 | Jul 2025 | grew EPS 8% to a record $3.98 | Achieved |
| Aerospace and Defense Sales Growth | flat | Jul 2025 | Organic aerospace and defense sales declined 3% as overall supply chain constraints, while incrementally improving in some areas persist. | Missed |
| Adjusted EPS | between $4.22 and $4.38 | Jul 2026 | All in, our EPS guidance for the full year is between $4.22 and $4.38, including approximately $0.12 of dilution from Facet when considering incremental amortization and additional interest expense. | New |
Claimed
Qualified
The full ledger
A free account opens 5 company ledgers a month. All 74 tracked commitments, with each call’s wording and source.
Call summaries
Donaldson Company Q4 FY26 — Record Sales and Operating Margin, Strong FY27 Outlook
Read the full callDonaldson Company Q3 FY26 — Record sales of $995M with all-time-high adjusted operating margin
Read the full callDonaldson Company Q2 FY26 — Record Sales and Strategic Acquisition
Read the full callEvery analysed call
Financials
Net profit, against the quarter before: +2854304536% (quarter to jul 2026 against jun 2026).
| Line item | Sep 2025 | Oct 2025 | Dec 2025 | Jan 2026 | Mar 2026 | Apr 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 935 | 0 | 896 | 0 | 995 | 0 | 1,059 |
| Expenses | 0 | — | 0 | — | 0 | — | 0 | — |
| Operating profit | 0 | 149 | 0 | 119 | 0 | 155 | 0 | 177 |
| Operating margin | 5.5% | 16.0% | 5.2% | 13.2% | 4.3% | 15.6% | 4.7% | 16.7% |
| Other income | 0 | — | 0 | — | 0 | — | 0 | — |
| Interest | 0 | 7 | 0 | 8 | 0 | 7 | 0 | 15 |
| Depreciation | 0 | — | 0 | — | 0 | — | 0 | — |
| Profit before tax | 0 | 148 | 0 | 117 | 0 | 155 | 0 | 167 |
| Tax rate | 28.1% | 22.8% | 21.8% | 20.7% | 23.0% | 23.7% | 27.8% | 22.5% |
| Net profit | 0 | 114 | 0 | 93 | 0 | 118 | 0 | 129 |
| EPS ($ per share) | 3.13 | 0.98 | 4.06 | 0.80 | 3.53 | 1.02 | 2.76 | — |
| Line item | Jul 2019 | Jul 2020 | Jul 2021 | Jul 2022 | Jul 2023 | Jul 2024 | Jul 2025 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 758 | 758 | 758 | 758 | 758 | 758 | 758 | 758 |
| Reserves | 1,282 | 1,430 | 1,608 | 1,846 | 2,088 | 2,378 | 2,610 | 2,920 |
| Total liabilities | 1,240 | 1,241 | 1,263 | 1,467 | 1,450 | 1,425 | 1,524 | 2,222 |
| Fixed assets | 589 | 632 | 618 | 594 | 653 | 646 | 645 | 633 |
| Total assets | 2,143 | 2,245 | 2,400 | 2,600 | 2,771 | 2,914 | 2,977 | 3,987 |
| Line item | Jul 2019 | Jul 2020 | Jul 2021 | Jul 2022 | Jul 2023 | Jul 2024 | Jul 2025 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 346 | 387 | 402 | 253 | 545 | 493 | 419 | 494 |
| Cash from investing | -246 | -129 | -58 | -154 | -327 | -87 | -150 | -879 |
| Cash from financing | -123 | -199 | -363 | -114 | -222 | -356 | -322 | 452 |
| Net cash flow | -27 | 59 | -14 | -29 | -6 | 46 | -52 | 70 |
| Capital expenditure | -151 | -124 | -59 | -85 | -118 | -86 | -79 | -67 |
| Free cash flow | 195 | 263 | 343 | 167 | 426 | 407 | 340 | 426 |
| Segment | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Industrial Solutions | — | — | — | — | 28% | 29% | 28% | 32% | — |
| Life Sciences | 8% | 8% | 8% | 8% | 8% | 9% | 8% | 9% | +9.7% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Q4 FY2026 · share of revenue
As DCI cuts its regions in its filings; they can nest, so they need not add to 100%.
58 filings between Dec 5, 2025 and Oct 2, 2026.
Purchases
None
No insider bought shares.
Sales
$8.58M
11 sales by 5 insiders
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Carpenter Tod E. | — | $3.19M | Sep 4, 2026 |
| Rajendra Ajita G | — | $1.82M | Dec 5, 2025 |
| Owens James | — | $1.77M | Apr 14, 2026 |
| Briseno Guillermo | — | $1.75M | Mar 26, 2026 |
| Pogalz Bradley J. | — | $51.8K | Dec 9, 2025 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Rautio Trudy A. Director | Award | 336 | $29.8K |
| Oct 2, 2026 | Smiley Jacinth C Director | Award | 268 | $23.8K |
| Oct 2, 2026 | Hilger Christopher M. Director | Award | 402 | $35.6K |
| Oct 2, 2026 | Owens James Director | Award | 268 | $23.8K |
| Sep 24, 2026 | Becker Amy C Chief Legal Officer | Award | 5,983 | $0 |
| Sep 24, 2026 | Carpenter Tod E. Chairman, President and CEO | Tax withheld | 18,761 | $1.62M |
| Sep 24, 2026 | Becker Amy C Chief Legal Officer | Tax withheld | 2,944 | $255.0K |
| Sep 24, 2026 | Carpenter Tod E. Chairman, President and CEO | Award | 38,131 | $0 |
| Sep 24, 2026 | Driesen Bart C. President | Tax withheld | 2,661 | $230.4K |
| Sep 24, 2026 | Lewis Richard Brent President | Award | 6,340 | $0 |
| Sep 24, 2026 | Driesen Bart C. President | Award | 4,465 | $0 |
| Sep 24, 2026 | Lewis Richard Brent President | Tax withheld | 149 | $12.9K |
| Sep 4, 2026 | Carpenter Tod E. Chairman, President and CEO | Sale | 31,968 | $2.91M |
| Sep 4, 2026 | Carpenter Tod E. Chairman, President and CEO | Option exercise | 31,968 | $1.37M |
| Aug 31, 2026 | Carpenter Tod E. Chairman, President and CEO | Sale | 3,032 | $275.9K |
| Aug 31, 2026 | Carpenter Tod E. Chairman, President and CEO | Option exercise | 3,032 | $129.5K |
| Aug 27, 2026 | Pogalz Bradley J. Chief Financial Officer | Option exercise | 3,000 | $128.2K |
| Aug 27, 2026 | Pogalz Bradley J. Chief Financial Officer | Tax withheld | 2,129 | $195.5K |
| Jul 3, 2026 | Rautio Trudy A. Director | Award | 334 | $29.8K |
| Jul 3, 2026 | Owens James Director | Award | 267 | $23.8K |
| Jul 3, 2026 | Hilger Christopher M. Director | Award | 400 | $35.6K |
| Jul 3, 2026 | Smiley Jacinth C Director | Award | 267 | $23.8K |
| Apr 14, 2026 | Owens James Director | Sale | 6,600 | $588.8K |
| Apr 14, 2026 | Owens James Director | Option exercise | 6,600 | $323.1K |
| Apr 14, 2026 | Owens James Director | Sale | 7,153 | $638.1K |
| Apr 14, 2026 | Owens James Director | Option exercise | 7,153 | $302.3K |
| Apr 13, 2026 | Owens James Director | Option exercise | 5,921 | $250.2K |
| Apr 13, 2026 | Owens James Director | Sale | 5,921 | $527.1K |
| Apr 10, 2026 | Owens James Director | Option exercise | 126 | $5.3K |
| Apr 10, 2026 | Owens James Director | Sale | 126 | $11.2K |
| Apr 3, 2026 | Rautio Trudy A. Director | Award | 349 | $29.7K |
| Apr 3, 2026 | Owens James Director | Award | 279 | $23.8K |
| Apr 3, 2026 | Smiley Jacinth C Director | Award | 279 | $23.8K |
| Apr 3, 2026 | Hilger Christopher M. Director | Award | 418 | $35.6K |
| Mar 26, 2026 | Briseno Guillermo President | Sale | 12,000 | $1.02M |
| Mar 26, 2026 | Briseno Guillermo President | Option exercise | 12,000 | $512.6K |
| Mar 26, 2026 | Briseno Guillermo President | Sale | 8,600 | $730.7K |
| Mar 26, 2026 | Briseno Guillermo President | Option exercise | 8,600 | $390.7K |
| Jan 2, 2026 | Hilger Christopher M. Director | Award | 900 | $0 |
| Jan 2, 2026 | Hilger Christopher M. Director | Award | 375 | $33.7K |
| Jan 2, 2026 | Cruz Pilar Director | Award | 900 | $0 |
| Jan 2, 2026 | Owens James Director | Award | 250 | $22.5K |
| Jan 2, 2026 | Owens James Director | Award | 900 | $0 |
| Jan 2, 2026 | Smiley Jacinth C Director | Award | 250 | $22.5K |
| Jan 2, 2026 | Shine Daniel P Director | Award | 900 | $0 |
| Jan 2, 2026 | Smiley Jacinth C Director | Award | 900 | $0 |
| Jan 2, 2026 | Rautio Trudy A. Director | Award | 311 | $28.0K |
| Jan 2, 2026 | Rajendra Ajita G Director | Award | 900 | $0 |
| Jan 2, 2026 | Olson Richard M Director | Award | 900 | $0 |
| Jan 2, 2026 | Milroy Douglas A. Director | Award | 900 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow DONALDSON Co INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading